Complement in health and disease

被引:167
|
作者
Carroll, Maria V. [1 ]
Sim, Robert B. [1 ]
机构
[1] Univ Oxford, Dept Pharmacol, Oxford OX1 3QT, England
关键词
Complement; Innate immunity; Blood plasma; Collectins; Inflammation; Phagocytosis; Opsonisation; Autoimmunity; Infection; Disease; MANNOSE-BINDING PROTEIN; PATTERN-RECOGNITION MOLECULES; SYSTEMIC-LUPUS-ERYTHEMATOSUS; HUMAN FACTOR-H; LECTIN PATHWAY ACTIVATION; GUINEA-PIG SERUM; L-FICOLIN; 1ST COMPONENT; ALTERNATIVE-PATHWAY; SERINE PROTEASES;
D O I
10.1016/j.addr.2011.06.005
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The complement system consists of about 35-40 proteins and glycoproteins present in blood plasma or on cell surfaces. Its main biological function is to recognise "foreign" particles and macromolecules, and to promote their elimination either by opsonisation or lysis. Although historically complement has been studied as a system for immune defence against bacteria, it has an important homeostatic role in which it recognises damaged or altered "self" components. Thus complement has major roles in both immune defence against microorganisms, and in clearance of damaged or "used" host components. Since complement proteins opsonise or lyse cells, complement can damage healthy host cells and tissues. The system is regulated by many endogenous regulatory proteins. Regulation is sometimes imperfect and both too much and too little complement activation is associated with many diseases. Excessive or inappropriate activation can cause tissue damage in diseases such as rheumatoid arthritis, age-related macular degeneration (AMD), multiple sclerosis, ischemia-reperfusion injury (e.g. ischemic stroke). Insufficient complement activity is associated with susceptibility to infection (mainly bacterial) and development of autoimmune disease, like SLE (systemic lupus erythematosus). (C) 2011 Elsevier B.V. All rights reserved.
引用
收藏
页码:965 / 975
页数:11
相关论文
共 50 条
  • [21] Factor H: A Complement Regulator in Health and Disease, and a Mediator of Cellular Interactions
    Kopp, Anne
    Hebecker, Mario
    Svobodova, Eliska
    Jozsi, Mihaly
    BIOMOLECULES, 2012, 2 (01) : 46 - 75
  • [22] Contribution of the Complement System to Realization of Biological Fluid Cytotoxicity in Health and Disease
    E. N. Arkhipova
    A. B. Cherepov
    Yu. S. Medvedeva
    I. B. Alchinova
    M. Yu. Karganov
    Bulletin of Experimental Biology and Medicine, 2012, 153 : 658 - 660
  • [23] Canonical and non-canonical functions of the complement system in health and disease
    Wenzel, Ulrich
    Kemper, Claudia
    Koehl, Joerg
    BRITISH JOURNAL OF PHARMACOLOGY, 2021, 178 (14) : 2751 - 2753
  • [24] MODULATION BY COMPLEMENT OF IMMUNE-COMPLEX PROCESSING IN HEALTH AND DISEASE IN MAN
    NYDEGGER, UE
    KAZATCHKINE, MD
    PROGRESS IN ALLERGY, 1986, 39 : 361 - 392
  • [25] THE INDEX OF THE COMPLEMENT ACTIVATION IN THE BODY - A NEW APPROACH TO ASSESSMENT OF THE COMPLEMENT-SYSTEM FUNCTIONING IN HUMANS IN HEALTH AND DISEASE
    KOVALEV, BM
    LABORATORNOE DELO, 1988, (06): : 65 - 67
  • [26] Modeling the activation of the alternative complement pathway and its effects on hemolysis in health and disease
    Caruso, Antonello
    Vollmer, Jannik
    Machacek, Matthias
    Kortvely, Elod
    PLOS COMPUTATIONAL BIOLOGY, 2020, 16 (10)
  • [27] Complement and kidney disease
    Cook, H. Terence
    CURRENT OPINION IN NEPHROLOGY AND HYPERTENSION, 2013, 22 (03): : 295 - 301
  • [28] COMPLEMENT IN HUMAN DISEASE
    SCHUR, PH
    AUSTEN, KF
    ANNUAL REVIEW OF MEDICINE, 1968, 19 : 1 - +
  • [29] Complement in Neurologic Disease
    Propson, Nicholas E.
    Gedam, Manasee
    Zheng, Hui
    ANNUAL REVIEW OF PATHOLOGY: MECHANISMS OF DISEASE, VOL 16, 2021, 2021, 16 : 277 - 298
  • [30] COMPLEMENT POLYMORPHISM AND DISEASE
    HOBART, MJ
    WALPORT, MJ
    LACHMANN, PJ
    CLINICS IN IMMUNOLOGY AND ALLERGY, 1984, 4 (03): : 647 - 664